Kidney outcomes associated with haematuria and proteinuria trajectories among patients with IgA nephropathy in real-world clinical practice: The Japan Chronic Kidney Disease Database.
Yano Y, Nagasu H, Kanegae H, Nangaku M, Hirakawa Y, Sugawara Y, Nakagawa N, Wada J, Sugiyama H, Nakano T, Wada T, Shimizu M, Suzuki H, Komatsu H, Nakashima N, Kitaoka K, Narita I, Okada H, Suzuki Y, Kashihara N.
Nephrology (Carlton). 2024 Feb;29(2):65-75. PMID: 37871587
Survey of Japanese nephrologists use of clinical practice guidelines for rapidly progressive glomerulonephritis. Takahashi-Kobayashi M, Sada KE, Kawashima S, Miyawaki Y, Nakazawa D, Furuichi K, Okada H, Narita I, Usui J. Clin Exp Nephrol. 2024 Apr;28(4):316-324. PMID: 38151607
Preference for anti-phospholipase A2 receptor antibody assay in patients with suspected membranous nephropathy: a survey study on medical practice after publication of Japanese Guidelines for Nephrotic Syndrome 2020. Sasaki S, Shimizu S, Nakaya I, Miyaoka Y, Koizumi M, Nishiwaki H, Sofue T, Ishimoto T, Kurita N, Wada T. Clin Exp Nephrol. 2024 Jun;28(6):531-538. PMID: 38402500
Japanese clinical practice patterns of rituximab treatment for minimal change disease in adults 2021: A web-based questionnaire survey of certified nephrologists. Koizumi M, Ishimoto T, Shimizu S, Sasaki S, Kurita N, Wada T. PLoS One. 2024 Mar 29;19(3):e0299053. PMID: 38551948
A case series of Fabry diseases with CKD in Japan.
Yusei O, Nagasu H, Nakagawa N, Terawaki S, Moriwaki T, Itano S, Kishi S, Sasaki T, Kashihara N, Otomo T.
Clin Exp Nephrol . 2024 May;28(5):404-408. PMID: 38193991